| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 40.873 | 204.629 | 493.088 | 687.482 | 1.101.726 | 1.500.912 | 2.078.220 | 3.270.062 | 4.289.460 | 3.239.223 |
| Venituri Totale - Ron | 66.403 | 204.630 | 493.168 | 687.588 | 1.102.023 | 1.501.989 | 2.082.249 | 3.280.412 | 4.355.025 | 3.280.883 |
| Cheltuieli Totale - Ron | 63.662 | 135.479 | 432.033 | 367.277 | 526.992 | 936.937 | 1.368.941 | 2.387.413 | 2.975.503 | 2.526.480 |
| Profit/Pierdere Brut - Ron | 2.741 | 69.151 | 61.135 | 320.311 | 575.031 | 565.052 | 713.308 | 892.999 | 1.379.522 | 754.403 |
| Profit/Pierdere Net - Ron | 1.513 | 63.012 | 55.849 | 313.435 | 566.215 | 553.135 | 699.161 | 869.272 | 1.341.806 | 652.572 |
| Salariati | 1 | 1 | 1 | 3 | 3 | 5 | 7 | 6 | 8 | 8 |
Verifica rapoartele financiare pentru firma - Novartis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 30.674 | 11.567 | 75.621 | 53.735 | 152.483 | 435.829 | 1.143.125 | 1.364.722 | 1.843.460 | 2.063.014 |
| Active Circulante | 31.323 | 86.759 | 126.477 | 469.872 | 687.903 | 675.226 | 669.573 | 711.468 | 1.633.384 | 1.332.279 |
| Stocuri | 2.218 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creante | 6.201 | 415 | 22.185 | 45.908 | 93.249 | 128.455 | 127.899 | 218.279 | 612.751 | 528.587 |
| Casa si conturi | 22.904 | 86.344 | 104.292 | 423.964 | 594.654 | 546.771 | 541.674 | 493.189 | 1.020.633 | 803.692 |
| Capitaluri Proprii | 1.848 | 64.860 | 120.709 | 411.884 | 737.725 | 990.860 | 1.490.021 | 1.546.709 | 2.887.395 | 2.974.158 |
| Capital Social | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 400 | 400 | 400 |
| Datorii | 60.149 | 28.466 | 85.087 | 116.302 | 107.240 | 120.195 | 322.677 | 529.481 | 600.329 | 440.672 |
| Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "7111 - 7111" | |||||||||
| CAEN An Financiar |
7111
|
|||||||||
Comentarii - Novartis Srl